# NILOTINIB HYDROCHLORIDE
> **ANDA209651** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-11-19
## Drug
- **FDA Application Number:** ANDA209651
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NILOTINIB HYDROCHLORIDE
- **Generic name:** NILOTINIB
- **Active ingredients:** NILOTINIB HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2025-11-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209651)
---
*AI Analytics · CC0 1.0*